Rutgers, The State University of New Jersey
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rutgers, The State University of New Jersey sits in the top decile of US sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count).
Rutgers, The State University of New Jersey: 413 sponsored US clinical trials, 109 recruiting.
Rutgers, The State University of New Jersey sponsors 413 registered US clinical trials on ClinicalTrials.gov, 109 of them currently recruiting, and 196 completed. 35 of these trials are in Phase 3-4 (later-stage) and 104 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 6 trials.
Top-decile sponsor footprint
Rutgers, The State University of New Jersey ranks in the top decile of sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
196 of 267 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (73.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
413 total, page 1 of 9
Exercise and Intranasal Insulin in Type 2 Diabetes
NCT07675499
Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children
NCT07188779
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
NCT07643012
Sun Safe Together: A Digital Skin Cancer Prevention Intervention for Adolescents and Their Parents
NCT07681791
Cigarette Filter Study
NCT07348679
Effects of Latin Dancing on Sleep Quality in Hispanic Cancer Survivors
NCT06844981
Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
NCT06814184
Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
NCT07402473
Finding Emotional Empowerment and Lifelong Strength
NCT07378254
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
NCT06822010
Use of the Electronic Medical Record to Screen Code Status Preference Using Death Language
NCT07405710
Manualized Assessment and Treatment Model of Challenging Behavior
NCT05928247
HIV Suicide Prevention With AI-DBT
NCT07339189
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
NCT07210567
Post Operative Infusion Pump Pain Study
NCT07349810
Pelashield™ PainGuard™ vs Restrata® in HS Surgery
NCT07316192
Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
NCT06995638
Acquired Dyslexia Modeling and Treatment
NCT07209488
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
NCT07171684
Rutgers University Study of the Genetics of Kidney Disease
NCT07217535
Clean Beauty in Newark, NJ
NCT07216898
RADA16 for Adult Tonsillectomy
NCT07060495
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
NCT07165691
R61/33 - VR Study Phase 4
NCT07169760
Project COMET: Massed Prolonged Exposure for PTSD and SUD
NCT06968832
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
NCT07158164
Rutgers University Study of the Genetics of Pulmonary Hypertension
NCT07217522
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
NCT06736431
Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder
NCT06642181
Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery
NCT06734975
Post-Operative Analgesic Selection in Patients Planned for Third Molar Extraction After Undergoing Shared Decision Making Using 2- Versus 3-Option Decision-Aids
NCT07011472
CBT-I in Older African American Adults
NCT06791356
Sleep Treatment for Teens (RCT Phase)
NCT07303959
A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening
NCT07008781
Bite Force Measurements
NCT06843525
Metabolic Health, Bones and Nuts During Weight Loss in Adults
NCT06949280
A Mobile Health Intervention Among Hispanics
NCT05389332
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
NCT06899191
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
NCT06797219
DECIDE to Improve Maternal Mental Health Care Delivery
NCT07098260
Extracellular Vesicles, Insulin Action, and Exercise
NCT06546085
Speech and Arm Combined Exergame
NCT06817941
Gait Adaptation Study
NCT07660601
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
NCT06745479
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT05736367
Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients
NCT06658574
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT06518837
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
NCT06663813
Student Exercise and Sleep Timing Study - Part 2
NCT06336590
Personalizing Treatment Delivery
NCT05821634
What is open in the Rutgers, The State University of New Jersey pipeline
109 recruiting of 413 indexed (26% open); 196 completed (47%).
Phase mix: 35 late (III/IV) vs 104 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rutgers, The State University of New Jersey: open-pipeline peers nationwide
Peers matched on 413 registered trials and 26% open enrollment, not the therapeutic-area sidebar.
Rutgers, The State University of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 413 trials (± recruiting share)
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
- Takeda · 408 trials · 12% recruiting
- University of Kansas Medical Center · 408 trials · 23% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
Sponsors near 26% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this Rutgers, The State University of New Jersey page
413 registered trials is a research-attention snapshot, not an endorsement of Rutgers, The State University of New Jersey or any single study.
- 109 of Rutgers, The State University of New Jersey's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Rutgers, The State University of New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rutgers, The State University of New Jersey pipeline card: 413 registered trials from official public datasets.Report a data error.